Key Insights

Highlights

Success Rate

94% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

3.2%

1 terminated out of 31 trials

Success Rate

94.1%

+7.6% vs benchmark

Late-Stage Pipeline

3%

1 trials in Phase 3/4

Results Transparency

6%

1 of 16 completed with results

Key Signals

1 with results94% success

Data Visualizations

Phase Distribution

16Total
Not Applicable (14)
P 2 (1)
P 3 (1)

Trial Status

Completed16
Unknown7
Recruiting2
Not Yet Recruiting2
Enrolling By Invitation1
Suspended1

Trial Success Rate

94.1%

Benchmark: 86.5%

Based on 16 completed trials

Clinical Trials (31)

Showing 20 of 20 trials
NCT06265311Not ApplicableCompleted

IDUS in CBD Stone Recurrence High Risk Patients

NCT07211828Not ApplicableRecruiting

EEG and Pain Monitor Data Under Anesthesia to Study Pharmacodynamic Effects of Opioids and Sedatives

NCT06196164Not ApplicableActive Not Recruiting

A RCT of Low MBO Drainage Strategies

NCT05303662Completed

Prevalence of Multidrug Resistant Micro-organism Carriage in Patients Undergoing an ERCP in Four Different Countries

NCT05129449CompletedPrimary

A Clinical Study With the Medical Device PowerSpiral for Endoscopic Retrograde Cholangio-Pancreatography (ERCP)

NCT05246657RecruitingPrimary

EUS-guided Entero-biliary Anastomosis for Therapeutic Access in Benign Biliary Obstructions

NCT06676241Completed

One-stage and Delayed Laparoscopic Cholecystectomy After Endoscopic Retrograde Cholangiopancreatography with Endoscopic Sphincterotomy in Cholecystocholedocholithiasis

NCT06672991Completed

ERCP and LC for Cholecystocholedocholithiasis in Children: Should It Be Accomplished in One or Repeated Hospitalization?

NCT04572711Enrolling By InvitationPrimary

Prospective Evaluation of Biliary Tissue Sampling with ERCP

NCT06689033CompletedPrimary

High Flow Nasal Oxygen Versus Standard Nasal Oxygen in Endoscopic Retrograde Cholangiopancreatography Under Sedation

NCT06623513Phase 2Not Yet Recruiting

Efficacy and Safety of Parecoxib vs. Indomethacin in Preventing Post-ERCP Pancreatitis

NCT04559867Not ApplicableSuspendedPrimary

Fistulotomy as the Primary Cannulation Technique for All Patients Undergoing ERCP: A Randomized, Controlled Trial

NCT05533944Not ApplicableCompletedPrimary

Fast-tracking ERCP Learning: Does Training on a Mechanical Simulator Improve Trainee's Clinical Performance?

NCT06031363Not ApplicableCompleted

The Optimal Dose of Indomethacin Suppository for Preventing Post-ERCP Pancreatitis

NCT06310460Not Yet RecruitingPrimary

Evaluation of "PreCut-Papillectomy" in Difficult Biliary Cannulation

NCT03561441Not ApplicableCompletedPrimary

Tailored Hydration for the Prevention of Post-ERCP Pancreatitis

NCT03490383CompletedPrimary

Study of Microbiota in Bile From Patients With Common Bile Duct Stone During ERCP

NCT05728073Completed

Does Subtotal Cholecystectomy Rate for Acute Cholecystitis Change With a Previous ERCP?

NCT03263481Not ApplicableCompletedPrimary

Intraductal Secretin Stimulation Test: What Is the Proper Collection Time?

NCT05592795UnknownPrimary

Explore the Effects and Mechanisms of ERCP and EST on Biliary Microecology

Scroll to load more

Research Network

Activity Timeline